Esaki R - Search Results

1

Conduction system abnormalities in alcoholics with asymptomatic valvular disease who suffer sudden death.

Nishida N, Ikeda N, Esaki R, Kudo K, Tsuji A. Nishida N, et al. Among authors: esaki r. Leg Med (Tokyo). 2003 Dec;5(4):212-9. doi: 10.1016/j.legalmed.2003.07.001. Leg Med (Tokyo). 2003. PMID: 14602164

2

Two cases of sudden death in obese psychiatric patients with microscopic cardiopulmonary abnormalities.

Nishida N, Kudo K, Esaki R, Ikeda N. Nishida N, et al. Among authors: esaki r. Fukuoka Igaku Zasshi. 2003 Apr;94(4):66-74. Fukuoka Igaku Zasshi. 2003. PMID: 12854508 Free article.

3

Sudden unexpected death of a methamphetamine abuser with cardiopulmonary abnormalities: a case report.

Nishida N, Ikeda N, Kudo K, Esaki R. Nishida N, et al. Among authors: esaki r. Med Sci Law. 2003 Jul;43(3):267-71. doi: 10.1258/rsmmsl.43.3.267. Med Sci Law. 2003. PMID: 12899434

4

Unexpected death due to right-sided infective endocarditis in a methamphetamine abuser.

Takasaki T, Nishida N, Esaki R, Ikeda N. Takasaki T, et al. Among authors: esaki r. Leg Med (Tokyo). 2003 Mar;5(1):65-8. doi: 10.1016/s1344-6223(02)00058-5. Leg Med (Tokyo). 2003. PMID: 12935653

5

Acute cerebral infarction caused by congenital hypoplasty of cerebral artery in a severe burn case.

Nishida N, Ikeda N, Tsuji A, Esaki R. Nishida N, et al. Among authors: esaki r. Leg Med (Tokyo). 2002 Jun;4(2):119-22. doi: 10.1016/s1344-6223(01)00052-9. Leg Med (Tokyo). 2002. PMID: 12935679

6

Meclozine and growth hormone ameliorate bone length and quality in experimental models of achondroplasia.

Sawamura K, Matsushita M, Esaki R, Mishima K, Kamiya Y, Ohno K, Kitoh H, Imagama S. Sawamura K, et al. Among authors: esaki r. J Bone Miner Metab. 2024 Nov 8. doi: 10.1007/s00774-024-01563-x. Online ahead of print. J Bone Miner Metab. 2024. PMID: 39514089

7

Long-term oral meclozine administration improves survival rate and spinal canal stenosis during postnatal growth in a mouse model of achondroplasia in both sexes.

Funahashi H, Matsushita M, Esaki R, Mishima K, Ohkawara B, Kamiya Y, Takegami Y, Ohno K, Kitoh H, Imagama S. Funahashi H, et al. Among authors: esaki r. JBMR Plus. 2024 Feb 24;8(4):ziae018. doi: 10.1093/jbmrpl/ziae018. eCollection 2024 Apr. JBMR Plus. 2024. PMID: 38544920 Free PMC article.

8

Activated FGFR3 promotes bone formation via accelerating endochondral ossification in mouse model of distraction osteogenesis.

Osawa Y, Matsushita M, Hasegawa S, Esaki R, Fujio M, Ohkawara B, Ishiguro N, Ohno K, Kitoh H. Osawa Y, et al. Among authors: esaki r. Bone. 2017 Dec;105:42-49. doi: 10.1016/j.bone.2017.05.016. Epub 2017 Aug 10. Bone. 2017. PMID: 28802681

9

Clinical dosage of meclozine promotes longitudinal bone growth, bone volume, and trabecular bone quality in transgenic mice with achondroplasia.

Matsushita M, Esaki R, Mishima K, Ishiguro N, Ohno K, Kitoh H. Matsushita M, et al. Among authors: esaki r. Sci Rep. 2017 Aug 7;7(1):7371. doi: 10.1038/s41598-017-07044-8. Sci Rep. 2017. PMID: 28785080 Free PMC article.

10

Activated FGFR3 prevents subchondral bone sclerosis during the development of osteoarthritis in transgenic mice with achondroplasia.

Okura T, Matsushita M, Mishima K, Esaki R, Seki T, Ishiguro N, Kitoh H. Okura T, et al. Among authors: esaki r. J Orthop Res. 2018 Jan;36(1):300-308. doi: 10.1002/jor.23608. Epub 2017 Jun 6. J Orthop Res. 2018. PMID: 28520086 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters